# Boehringer Ingelheim Pharma Gmbh & Co Kg – FDA Inspection, Mar 19, 2013

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/b82b9c1c-8e5d-4af2-b32e-7c891abab0fd
Source feed: FDA_Inspections

> FDA inspection 826498 of Boehringer Ingelheim Pharma Gmbh & Co Kg, March 19, 2013. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 826498
- Company Name: Boehringer Ingelheim Pharma Gmbh & Co Kg
- Inspection Date: 2013-03-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1208927 - 2022-07-22
- [FDA Inspection 1102691 - 2019-09-19](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/db6a02f0-3ebc-4c6a-b689-a50299bdaa08)
- FDA Inspection 1107587 - 2019-08-15
- [FDA Inspection 1086418 - 2019-04-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61)
- FDA Inspection 1072835 - 2018-10-19

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
